Results 161 to 170 of about 370,724 (274)

Health and Survival Impacts of Early Childhood Development Programmes: The Case of the Happy Child Programme in Brazil

Review of Development Economics, EarlyView.
ABSTRACT This paper adds to the growing evidence on the impacts of early childhood development (ECD) programming by examining one of the world's largest home visitation programmes, the Happy Child Programme in Brazil, and its impacts on child vaccination and preventable death rates.
Raquel Tebaldi, Franziska Gassmann, Bruno Martorano   +2 more
wiley   +1 more source

National Immunisation Office Strategic Plan 2024-2027

This strategy was developed collaboratively by the multidisciplinary team within the National Immunisation Office (NIO). A workshop with NIO staff was held in June 2023 and nominal group technique was used to develop the vision and priorities for the NIO.
National Immunisation Office
core  

Short-Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey-Based Surveillance Study. [PDF]

Med J Aust
Nguyen T, Tay ECS, Dymock M, Snelling TL, Dawes L, Marsh J, Wu Y, Leeb A, Wood N, Deng L.   +9 more
europepmc   +1 more source

Assessing full immunisation coverage using lot quality assurance sampling in urban and rural districts of southwest Nigeria

, 2013
Background: This study was conducted to identify administrative wards (lots) with unacceptable levels of full child immunisation coverage, and to identify factors associated with achievement of a complete child immunisation schedule in Ibadan North East (
Adebowale, A. S., Fatiregun, A. A., Ayoka, R. O., Fagbamigbe, A. F.   +3 more
core  

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

Transplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia, Britta L. Hirsch, Irene A. Abela, Karen E. Doucette   +3 more
wiley   +1 more source

Reactogenicity and Immunogenicity of RSV Vaccines in Immunocompromised Individuals With Hematological Malignancies

Transplant Infectious Disease, EarlyView.
In adults with hematologic malignancies, RSV vaccination was safe and induced antibody and T‐cell responses. However, antibody levels were lower and declined more rapidly than in healthy controls. While early immune responses were evident, reduced magnitude and durability of protection suggest the need for optimized vaccination strategies in this high ...
Alisse Hannaford, Zoe Swank, Simon D. van Haren, Natalie Izaguirre, Caitlin Syphurs, Zhou Lan, Bridget Yates, Urwah Kanwal, Grace Valentine, Ella Woehl, David Regan, Hannah Levine, Alexandra Tong, Maria Shehata, Fathia Oladipupo, Colleen Sedney, Kevin Ryff, Sanya Thomas, Joann Diray‐Arce, Xiaofang Li, Kimberly A. Dufresne, Lindsey A. Parisi, Aidan Eustace, Louise Hansen, David R. Walt, Ofer Levy, Amar Kelkar, Robert J. Soiffer, Vincent T. Ho, Lindsey R. Baden, Nicolas C. Issa, Ann E. Woolley, Amy C. Sherman   +32 more
wiley   +1 more source

Viral Hepatitis A, B and C in Roraima, Brazilian Amazon: Epidemiological and Serological Profile, 2012–2023

Tropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Viral hepatitis remains a major global public health challenge, with heterogeneous epidemiological patterns across geographic and socioeconomic contexts. In the Brazilian Amazon, evidence remains limited, particularly regarding long‐term trends.
Jamilla Karla Corrêa Reis, Katrini Guidolini Martinelli, Flávia Freitas de Oliveira Bonfim, Cícera Raquel Feitosa, Bianca Jorge Sequeira, Livia Melo Villar, Vanessa Salete de Paula   +6 more
wiley   +1 more source

Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol. [PDF]

BMJ Open
Aslam R, Akeju O, Clutterbuck E, Appleby C, Murphy D, De Calignon A, Muller J, White R, Singha A, Mujadidi YF, Roderick M, Turner DPJ, Heath PT, Owens D, Goldblatt D, Ebrahimi N, Liu X, Faust S, Ramasamy MNN, Kelly D.   +19 more
europepmc   +1 more source

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

International Journal of Cancer, Volume 160, Issue 1, Page 171-186, 1 January 2027.
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold, Ida Laake, Berit Feiring, Kristiane Søreng, Gro Kummeneje Presthus, Glenny Cecilie Alfsen, Irene Kraus Christiansen, Mona Hansen, Hanne Kristiansen, Eirik Olsen, Torstein Gjølgali Frengen, Emily A. Burger, Christine Genieve Monceyron Jonassen, Lill Trogstad   +13 more
wiley   +1 more source

Does the Emergency Department Have a Role in Immunisation? Yes-But Not as a Routine Vaccine Clinic. [PDF]

Emerg Med Australas
Ricks TA, Bouchoucha SL.
europepmc   +1 more source